We found a matchYour institution may have access to this item. Find your institution then sign in to continue.Title(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.AuthorsAbou-Nassar KE; Stevenson KE; Antin JH; McDermott K; Ho VT; Cutler CS; LaCasce AS; Jacobsen ED; Fisher DC; Soiffer RJ; Alyea EP; Koreth J; Freedman ASPublicationBone marrow transplantation, 2011, Vol 46, Issue 12, p1503ISSN1476-5365Publication typearticleDOI10.1038/bmt.2010.339